MUC4 as a diagnostic marker in cancer

Subhankar Chakraborty, Maneesh Jain, Aaron R. Sasson, Surinder Kumar Batra

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Background: Mucins are high molecular mass glycoproteins whose role in diagnosis, prognosis and therapy is being increasingly recognized owing to their altered expression in a variety of carcinomas. MUC4, a membrane-bound mucin encoded by a gene located on chromosome locus 3q29, is aberrantly expressed in several cancers including those of the bile duct, breast, colon, esophagus, ovary, lung, prostate, stomach and pancreas. Objective: This review considers the potential use of the MUC4 expression pattern in the diagnosis and prognosis of various cancers. Results/conclusion: MUC4 expression is a specific marker of epithelial tumors and its expression correlates positively with the degree of differentiation in several cancers. Importantly, MUC4 has emerged as a specific marker of clysplasia, being expressed in the earliest dysplastic lesions preceding several malignancies, including lethal pancreatic cancer. The presence of MUC4-specific antibodies in the serum and of the transcript in peripheral blood mononuclear cells of cancer patients raises the possibility of it emerging as a new diagnostic biomarker for bedaside application in high-risk individuals and those with established cancer.

Original languageEnglish (US)
Pages (from-to)891-910
Number of pages20
JournalExpert Opinion on Medical Diagnostics
Volume2
Issue number8
DOIs
StatePublished - Aug 1 2008

Fingerprint

Mucins
Glycoproteins
Molecular mass
Biomarkers
Chromosomes
Antibodies
Ducts
Tumors
Neoplasms
Blood
Genes
Membranes
Tumor Biomarkers
Bile Ducts
Pancreatic Neoplasms
Esophagus
Prostate
Pancreas
Ovary
Blood Cells

Keywords

  • Cancer
  • Diagnosis
  • MUC4

ASJC Scopus subject areas

  • Biomedical Engineering
  • Medicine(all)
  • Biochemistry, medical
  • Molecular Medicine

Cite this

MUC4 as a diagnostic marker in cancer. / Chakraborty, Subhankar; Jain, Maneesh; Sasson, Aaron R.; Batra, Surinder Kumar.

In: Expert Opinion on Medical Diagnostics, Vol. 2, No. 8, 01.08.2008, p. 891-910.

Research output: Contribution to journalReview article

Chakraborty, Subhankar ; Jain, Maneesh ; Sasson, Aaron R. ; Batra, Surinder Kumar. / MUC4 as a diagnostic marker in cancer. In: Expert Opinion on Medical Diagnostics. 2008 ; Vol. 2, No. 8. pp. 891-910.
@article{cecda2ef6dd54fe5bdc6aa5aa5069d43,
title = "MUC4 as a diagnostic marker in cancer",
abstract = "Background: Mucins are high molecular mass glycoproteins whose role in diagnosis, prognosis and therapy is being increasingly recognized owing to their altered expression in a variety of carcinomas. MUC4, a membrane-bound mucin encoded by a gene located on chromosome locus 3q29, is aberrantly expressed in several cancers including those of the bile duct, breast, colon, esophagus, ovary, lung, prostate, stomach and pancreas. Objective: This review considers the potential use of the MUC4 expression pattern in the diagnosis and prognosis of various cancers. Results/conclusion: MUC4 expression is a specific marker of epithelial tumors and its expression correlates positively with the degree of differentiation in several cancers. Importantly, MUC4 has emerged as a specific marker of clysplasia, being expressed in the earliest dysplastic lesions preceding several malignancies, including lethal pancreatic cancer. The presence of MUC4-specific antibodies in the serum and of the transcript in peripheral blood mononuclear cells of cancer patients raises the possibility of it emerging as a new diagnostic biomarker for bedaside application in high-risk individuals and those with established cancer.",
keywords = "Cancer, Diagnosis, MUC4",
author = "Subhankar Chakraborty and Maneesh Jain and Sasson, {Aaron R.} and Batra, {Surinder Kumar}",
year = "2008",
month = "8",
day = "1",
doi = "10.1517/17530059.2.8.891",
language = "English (US)",
volume = "2",
pages = "891--910",
journal = "Expert Opinion on Medical Diagnostics",
issn = "1753-0059",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - MUC4 as a diagnostic marker in cancer

AU - Chakraborty, Subhankar

AU - Jain, Maneesh

AU - Sasson, Aaron R.

AU - Batra, Surinder Kumar

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Background: Mucins are high molecular mass glycoproteins whose role in diagnosis, prognosis and therapy is being increasingly recognized owing to their altered expression in a variety of carcinomas. MUC4, a membrane-bound mucin encoded by a gene located on chromosome locus 3q29, is aberrantly expressed in several cancers including those of the bile duct, breast, colon, esophagus, ovary, lung, prostate, stomach and pancreas. Objective: This review considers the potential use of the MUC4 expression pattern in the diagnosis and prognosis of various cancers. Results/conclusion: MUC4 expression is a specific marker of epithelial tumors and its expression correlates positively with the degree of differentiation in several cancers. Importantly, MUC4 has emerged as a specific marker of clysplasia, being expressed in the earliest dysplastic lesions preceding several malignancies, including lethal pancreatic cancer. The presence of MUC4-specific antibodies in the serum and of the transcript in peripheral blood mononuclear cells of cancer patients raises the possibility of it emerging as a new diagnostic biomarker for bedaside application in high-risk individuals and those with established cancer.

AB - Background: Mucins are high molecular mass glycoproteins whose role in diagnosis, prognosis and therapy is being increasingly recognized owing to their altered expression in a variety of carcinomas. MUC4, a membrane-bound mucin encoded by a gene located on chromosome locus 3q29, is aberrantly expressed in several cancers including those of the bile duct, breast, colon, esophagus, ovary, lung, prostate, stomach and pancreas. Objective: This review considers the potential use of the MUC4 expression pattern in the diagnosis and prognosis of various cancers. Results/conclusion: MUC4 expression is a specific marker of epithelial tumors and its expression correlates positively with the degree of differentiation in several cancers. Importantly, MUC4 has emerged as a specific marker of clysplasia, being expressed in the earliest dysplastic lesions preceding several malignancies, including lethal pancreatic cancer. The presence of MUC4-specific antibodies in the serum and of the transcript in peripheral blood mononuclear cells of cancer patients raises the possibility of it emerging as a new diagnostic biomarker for bedaside application in high-risk individuals and those with established cancer.

KW - Cancer

KW - Diagnosis

KW - MUC4

UR - http://www.scopus.com/inward/record.url?scp=73349102719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73349102719&partnerID=8YFLogxK

U2 - 10.1517/17530059.2.8.891

DO - 10.1517/17530059.2.8.891

M3 - Review article

VL - 2

SP - 891

EP - 910

JO - Expert Opinion on Medical Diagnostics

JF - Expert Opinion on Medical Diagnostics

SN - 1753-0059

IS - 8

ER -